Cingulate (CING) announced that it held a Pre-NDA meeting with the U.S. Food and Drug Administration, FDA, yesterday to discuss the submission ...

Tovecimig (a DLL4 x VEGF-A bispecific antibody) in combination with paclitaxel achieved a 17.1% overall response rate (ORR), including one ...

Expanding on the success of the MLB Debut Patch, Topps, Major League Baseball and Nike have partnered to recognize baseball's elite performers from last season with custom gold-embellished MLB ...

LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions.

The best free logo maker is a great choice for those who need to create logos for their businesses without paying for subscriptions or licenses. I'll cut to the chase: for a free logo designer ...

The best logo maker is an essential design tool for anyone looking to differentiate their brand online. My round-up here offers apps ideal for designers and non-designers who need to help their ...

LUXTURNA has significant market potential due to the high unmet need for effective treatments in rare genetic conditions. With its FDA approval for specific mutations in the RPE65 gene, it offers hope ...

Unite.AI is committed to rigorous editorial standards. We may receive compensation when you click on links to products we review. Please view our affiliate disclosure. Creating a strong brand identity ...